Mark Duquette
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 6
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 13
- Cancer, Hypoxia, and Metabolism 4
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research 6
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 23
- Oncology top 10%
- CAR-T cell therapy research 3
-
- Axon Guidance and Neuronal Signaling 5
-
- Virus-based gene therapy research 2
Mark Duquette
36 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 107
- Immunology and Allergy 241
- Cancer Research 496
- Cell Biology 347
- Molecular Biology 1.4k
- Oncology 359
Countries citing papers authored by Mark Duquette
This map shows the geographic impact of Mark Duquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Duquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Duquette more than expected).
Fields of papers citing papers by Mark Duquette
This network shows the impact of papers produced by Mark Duquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Duquette. The network helps show where Mark Duquette may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Duquette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 79 | |
| 3 | 2014 | 28 | |
| 4 | 2014 | 13 | |
| 5 | 2014 | 56 | |
| 6 | 2013 | 19 | |
| 7 | 2012 | 22 | |
| 8 | 2009 | 44 | |
| 9 | 2008 | 19 | |
| 10 | 2008 | 107 | |
| 11 | 2007 | 29 | |
| 12 | 2006 | 73 | |
| 13 | 2006 | 18 | |
| 14 | 2001 | 89 | |
| 15 | 1998 | 29 | |
| 16 | 1998 | 374 | |
| 17 | 1995 | 76 | |
| 18 | 1993 | 54 | |
| 19 | 1992 | 56 | |
| 20 | 1991 | 32 |
About Mark Duquette
Mark Duquette is a scholar working on Cancer Research, Immunology and Allergy and Cell Biology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (23 papers), Protease and Inhibitor Mechanisms (13 papers), Cell Adhesion Molecules Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers), Axon Guidance and Neuronal Signaling (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Immunology and Allergy (241 citations), Cancer Research (496 citations) and Cell Biology (347 citations). Mark Duquette has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Jack Lawler, Richard O. Hynes, Kemin Tan, A. Joachimiak, Elizabeth George, Helen Rayburn, Mary E. Sunday, Valérie Thibert, Jia‐Huai Wang and Jin‐huan Liu. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal, Cancer Research, Clinical Cancer Research and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.